Thus, the physiological relevance of the sumoylation pathway during AD is that it has a net overall positive effect on the PPARγ/RXR transcription program, which is also consistent with the lipoatrophy phenotype that we and others have observed upon inhibition of sumoylation (16,18). Here, PPARG is linked to Alzheimer disease.